Racial, Ethnic, and Gender Representation in Leadership Positions at National Cancer Institute-Designated Cancer Centers
- PMID: 34097046
- PMCID: PMC8185594
- DOI: 10.1001/jamanetworkopen.2021.12807
Racial, Ethnic, and Gender Representation in Leadership Positions at National Cancer Institute-Designated Cancer Centers
Abstract
Importance: Increasing diversity is beneficial for the health care system and patient outcomes; however, the current leadership gap in oncology remains largely unquantified.
Objective: To evaluate the gender, racial, and ethnic makeup of the leadership teams of National Cancer Institute (NCI)-designated cancer centers and compare with the city populations served by each center.
Design, setting, and participants: This retrospective cross-sectional study examined gender, race, and ethnicity of leadership teams via publicly available information for NCI-designated cancer centers and compared results with national and city US census population characteristics, as well as active physician data. Data were analyzed in August 2020.
Main outcomes and measures: Racial, ethnic, and gender diversity (identified via facial recognition software and manual review) of leadership teams compared with institution rank, location, team member degree(s), and h-index.
Results: All 63 NCI cancer centers were included in analysis, and all had identifiable leadership teams, with a total of 856 members. Photographs were not identified for 12 leaders (1.4%); of the remaining 844 leaders, race/ethnicity could not be identified for 7 (0.8%). Women make up 50.8% of the US population and 35.9% of active physicians; in NCI cancer centers, 36.3% (306 women) of cancer center leaders were women. Non-Hispanic White individuals comprise 60.6% of the US population and 56.2% of active physicians, but 82.2% of cancer center leaders (688 individuals) were non-Hispanic White. Both Black and Hispanic physicians were underrepresented when compared with their census populations (Black: 12.7% of US population, 5.0% of active physicians; Hispanic: 18.1% of US population, 5.8% of active physicians); however, Black and Hispanic individuals were even less represented in cancer center leadership positions (29 Black leaders [3.5%]; 32 Hispanic leaders [3.8%]). Asian physicians were overrepresented compared with their census population (5.6% of US population, 17.1% of active physicians); however, Asian individuals were underrepresented in leadership positions (92 Asian individuals [11.0%]). A total of 23 NCI cancer centers (36.5%) did not have a single Black or Hispanic member of their leadership team; 8 cancer centers (12.7%) had an all non-Hispanic White leadership team. A multivariate model found that leadership teams with more women (adjusted odds ratio, 1.73 [95% CI, 1.02-2.93]; P = .04) and institutions in the South (adjusted odds ratio, 2.31 [95% CI, 1.15 to 4.77]; P = .02) were more likely to have at least 1 Black or Hispanic leader. Pearson correlation analysis showed weak to moderate correlation between city Hispanic population and Hispanic representation on leadership teams (R = 0.5; P < .001), but no significant association between Black population and Black leadership was found.
Conclusions and relevance: This cross-sectional study found that significant racial and ethnic disparities were present in cancer center leadership positions. Establishing policy, as well as pipeline programs, to address these disparities is essential for change.
Conflict of interest statement
Figures


Similar articles
-
Diversification of Academic Surgery, Its Leadership, and the Importance of Intersectionality.JAMA Surg. 2021 Aug 1;156(8):748-756. doi: 10.1001/jamasurg.2021.1546. JAMA Surg. 2021. PMID: 33950242 Free PMC article.
-
Racial, Ethnic, and Gender Diversity Among Academic Surgical Leaders in the US.JAMA Surg. 2023 Dec 1;158(12):1328-1334. doi: 10.1001/jamasurg.2023.4777. JAMA Surg. 2023. PMID: 37819633 Free PMC article.
-
Estimation and Comparison of Current and Future Racial/Ethnic Representation in the US Health Care Workforce.JAMA Netw Open. 2021 Mar 1;4(3):e213789. doi: 10.1001/jamanetworkopen.2021.3789. JAMA Netw Open. 2021. PMID: 33787910 Free PMC article.
-
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640. JAMA Netw Open. 2021. PMID: 33606033 Free PMC article. Review.
-
Diversity is essential in cardiovascular medicine and subspecialties: A comprehensive report of gender, racial, and ethnic representation among cardiovascular fellows from 2005 to 2022.Curr Probl Cardiol. 2025 Jul;50(7):103067. doi: 10.1016/j.cpcardiol.2025.103067. Epub 2025 Apr 29. Curr Probl Cardiol. 2025. PMID: 40311855 Review.
Cited by
-
Increasing Diversity of Patients in Radiation Oncology Clinical Trials.Int J Radiat Oncol Biol Phys. 2023 May 1;116(1):103-114. doi: 10.1016/j.ijrobp.2022.11.044. Epub 2022 Dec 13. Int J Radiat Oncol Biol Phys. 2023. PMID: 36526234 Free PMC article. Review.
-
Mentorship Experiences Are Not All the Same: A Survey Study of Oncology Trainees and Early-Career Faculty.JCO Oncol Pract. 2023 Sep;19(9):808-818. doi: 10.1200/OP.22.00643. Epub 2023 May 16. JCO Oncol Pract. 2023. PMID: 37192431 Free PMC article.
-
Racial, Ethnic, and Sex Diversity Trends in Health Professions Programs From Applicants to Graduates.JAMA Netw Open. 2023 Dec 1;6(12):e2347817. doi: 10.1001/jamanetworkopen.2023.47817. JAMA Netw Open. 2023. PMID: 38153738 Free PMC article.
-
Stepping Up Summer Fun: the Cancer Research - Scholarship and Training Experience in Population Sciences (C-STEPS) Program.J Cancer Educ. 2025 Feb;40(1):3-10. doi: 10.1007/s13187-024-02458-1. Epub 2024 May 31. J Cancer Educ. 2025. PMID: 38819526 Free PMC article.
-
The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership.J Natl Cancer Inst. 2023 Oct 9;115(10):1132-1138. doi: 10.1093/jnci/djad121. J Natl Cancer Inst. 2023. PMID: 37364007 Free PMC article.
References
-
- Zeng C, Wen W, Morgans AK, Pao W, Shu XO, Zheng W. Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol. 2015;1(1):88-96. doi:10.1001/jamaoncol.2014.161 - DOI - PMC - PubMed
-
- McKinsey & Company . Delivering through diversity. Accessed November 12, 2020. https://www.mckinsey.com/~/media/mckinsey/business%20functions/organizat...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous